Bone Biologics Corp – ‘10-Q’ for 6/30/15 – ‘EX-10.2’

On:  Friday, 8/14/15, at 4:25pm ET   ·   For:  6/30/15   ·   Accession #:  1493152-15-3724   ·   File #:  0-53078

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    318K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     17K 
 3: EX-10.1     Material Contract                                   HTML     20K 
 4: EX-10.2     Material Contract                                   HTML     20K 
 5: EX-10.3     Material Contract                                   HTML     19K 
 6: EX-10.4     Material Contract                                   HTML     26K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     20K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     20K 
44: R1          Document and Entity Information                     HTML     38K 
34: R2          Condensed Consolidated Balance Sheets               HTML     75K 
42: R3          Condensed Consolidated Balance Sheets               HTML     41K 
                (Parenthetical)                                                  
46: R4          Condensed Consolidated Statements of Operations     HTML     63K 
                (Unaudited)                                                      
59: R5          Condensed Consolidated Statements of Cash Flows     HTML    101K 
                (Unaudited)                                                      
36: R6          The Company                                         HTML     30K 
41: R7          Summary of Significant Accounting Policies          HTML     53K 
31: R8          Property and Equipment                              HTML     28K 
24: R9          Accounts Payable and Accrued Expenses               HTML     26K 
60: R10         Commitments and Contingencies                       HTML     38K 
48: R11         Notes Payable to Related Party                      HTML     35K 
47: R12         Notes Payable                                       HTML     52K 
52: R13         Stockholders' Equity                                HTML     56K 
53: R14         Stock-Based Compensation                            HTML     62K 
51: R15         Income Taxes                                        HTML     27K 
54: R16         Related Party Transactions                          HTML     29K 
43: R17         Subsequent Events                                   HTML     48K 
45: R18         Summary of Significant Accounting Policies          HTML     93K 
                (Policies)                                                       
50: R19         Summary of Significant Accounting Policies          HTML     26K 
                (Tables)                                                         
64: R20         Property and Equipment (Tables)                     HTML     26K 
56: R21         Accounts Payable and Accrued Expenses (Tables)      HTML     26K 
38: R22         Notes Payable to Related Party (Tables)             HTML     29K 
49: R23         Notes Payable (Tables)                              HTML     31K 
40: R24         Stockholders' Equity (Tables)                       HTML     46K 
21: R25         Stock-Based Compensation (Tables)                   HTML     57K 
57: R26         The Company (Details Narrative)                     HTML     46K 
61: R27         Summary of Significant Accounting Policies          HTML     39K 
                (Details Narrative)                                              
27: R28         Summary of Significant Accounting Policies -        HTML     28K 
                Schedule of Antidilutive Securities Excluded from                
                Computation of Earnings Per Share (Details)                      
26: R29         Property and Equipment (Details Narrative)          HTML     21K 
29: R30         Property and Equipment - Schedule of Property and   HTML     29K 
                Equipment (Details)                                              
30: R31         Accounts Payable and Accrued Expenses - Schedule    HTML     31K 
                of Accounts Payable and Accrued Expenses (Details)               
32: R32         Commitments and Contingencies (Details Narrative)   HTML    100K 
20: R33         Notes Payable to Related Party (Details Narrative)  HTML     36K 
55: R34         Notes Payable to Related Party - Notes Outstanding  HTML     34K 
                (Principal and Interest) Including Unamortized                   
                Discount, with MTF Related Party (Details)                       
37: R35         Notes Payable (Details Narrative)                   HTML     79K 
39: R36         Notes Payable - Schedule of Note Payable (Details)  HTML     40K 
23: R37         Stockholders' Equity (Details Narrative)            HTML     63K 
63: R38         Stockholders' Equity - Schedule of Outstanding      HTML     75K 
                Unexercised Common Stock Warrants (Details)                      
17: R39         Stock-Based Compensation (Details Narrative)        HTML     30K 
33: R40         Stock-Based Compensation - Schedule of Stock        HTML     49K 
                Option Activity (Details)                                        
58: R41         Stock-Based Compensation - Schedule of Stock        HTML     29K 
                Option (Details)                                                 
22: R42         Stock-Based Compensation - Schedule of Non-Vested   HTML     45K 
                Options (Details)                                                
25: R43         Income Taxes (Details Narrative)                    HTML     24K 
28: R44         Related Party Transactions (Details Narrative)      HTML     51K 
35: R45         Subsequent Events (Details Narrative)               HTML     63K 
62: XML         IDEA XML File -- Filing Summary                      XML    101K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX     64K 
11: EX-101.INS  XBRL Instance -- boneb-20150630                      XML    874K 
13: EX-101.CAL  XBRL Calculations -- boneb-20150630_cal              XML    122K 
14: EX-101.DEF  XBRL Definitions -- boneb-20150630_def               XML    388K 
15: EX-101.LAB  XBRL Labels -- boneb-20150630_lab                    XML    869K 
16: EX-101.PRE  XBRL Presentations -- boneb-20150630_pre             XML    566K 
12: EX-101.SCH  XBRL Schema -- boneb-20150630                        XSD    153K 
18: ZIP         XBRL Zipped Folder -- 0001493152-15-003724-xbrl      Zip    106K 

‘EX-10.2’   —   Material Contract

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

18 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/24  Bone Biologics Corp.              S-1/A                  3:393K                                   M2 Compliance LLC/FA
 2/23/24  Bone Biologics Corp.              S-1/A                  7:1.3M                                   M2 Compliance LLC/FA
 2/21/24  Bone Biologics Corp.              10-K       12/31/23   63:6.3M                                   M2 Compliance LLC/FA
 1/30/24  Bone Biologics Corp.              S-1                   64:9.1M                                   M2 Compliance LLC/FA
11/20/23  Bone Biologics Corp.              10-K/A     12/31/22   14:425K                                   M2 Compliance LLC/FA
 6/13/23  Bone Biologics Corp.              S-1/A                  6:1M                                     M2 Compliance LLC/FA
 6/06/23  Bone Biologics Corp.              S-1/A                  6:1M                                     M2 Compliance LLC/FA
 5/01/23  Bone Biologics Corp.              S-1                    5:758K                                   M2 Compliance LLC/FA
 3/30/23  Bone Biologics Corp.              10-K       12/31/22   58:5.5M                                   M2 Compliance LLC/FA
10/05/22  Bone Biologics Corp.              S-1/A      10/04/22   59:8M                                     M2 Compliance LLC/FA
10/04/22  Bone Biologics Corp.              S-1/A                 59:8M                                     M2 Compliance LLC/FA
 9/23/22  Bone Biologics Corp.              S-1                   58:7.9M                                   M2 Compliance LLC/FA
 3/15/22  Bone Biologics Corp.              10-K       12/31/21   59:5M                                     M2 Compliance LLC/FA
10/07/21  Bone Biologics Corp.              S-1/A                 60:9.2M                                   M2 Compliance LLC/FA
10/06/21  Bone Biologics Corp.              S-1/A                 59:8.2M                                   M2 Compliance LLC/FA
 8/30/21  Bone Biologics Corp.              S-1/A                 60:7.8M                                   M2 Compliance LLC/FA
 6/28/21  Bone Biologics Corp.              S-1                   71:5.9M                                   M2 Compliance LLC/FA
 4/15/21  Bone Biologics Corp.              10-K       12/31/20   63:4.3M                                   M2 Compliance LLC/FA